(A) Super-resolution images of a human myotube expressing Cav3GFP and labelled with antibodies against RyR1 (red). (B) Quantification of ring diameter from super-resolution images of differentiated …
Quantification of ring diameter in Cav3GFP and immunolabeled myotubes.
Quantification of ring diameter from human and mouse myotubes on PREM.
Quantification of the number of caveolae per ring.
Quantification of the average caveolae diameter.
(A) Immunofluorescent DHPR (green) and Ryanodine receptor (RyR1) (red) labeling in primary mouse myotubes differentiated for 5 days. Labeling shows clusters of RyR1 and DHPR that appear …
(A) Bin1 antibody labels a tubular network extending from the plasma membrane forming contacts with RyR1-positive fluorescent dots. Blue arrowheads and white arrows denote tubular and circular Bin1 …
Quantification of ring diameter labeled by MemBright.
T-tubules from live primary mouse myotubes were stained with the MemBright lipid probe. Tubules emanate transversely from the sarcolemma and are mostly oriented longitudinally.
(A–C) EM images showing caveolae rings in contact with cortical endo/sarcoplasmic reticulum cisternae (pseudo-colored purple) on the cytosolic part of the adherent sarcolemma. Yellow arrows indicate …
(A–C) Two-color CLEM analysis in unroofed primary mouse myotubes transduced with GFP-tagged α1s-subunit of the DHPR (green) and labeled with antibodies against Cav3 (red). (C) Higher magnification …
The unroofed myotube is shown with successive fluorescent microscopy images (Cav3 in green, RyR1 in red), low-magnification PREM image (grid appears white), super-resolution image and …
(A–C) High magnification PREM views of caveolae rings on unroofed myotubes from primary mouse cultures. In (B) caveolae are pseudo-colored in light purple. White arrows indicate beaded tubes …
(A–D) Gallery of thin-section EM from the adherent surface of extensively differentiated mouse primary myotubes as in Figure 3D. The tubular structures emanating from the caveolae ring-like …
The unroofed myotube is shown with successive fluorescent microscopy images (Cav3 in green, Bin1 in red), low-magnification PREM image (grid appears white), super-resolution image and …
The unroofed myotube is shown with successive fluorescent microscopy images (Cav3 in green, Bin1 in red), low-magnification PREM image (grid appears white), super-resolution image and …
(A) Gallery of consecutive frames from two time-lapse sequences of Cav3GFP expressing human myotubes (green). The gallery shows four consecutive frames every 40 s followed by four consecutive frames …
Time-lapse shows a tubule emanating from a Cav3-positive ring acquired at 1 frame every 10 s using a spinning-disk microscope equipped with a SR module.
Time-lapse shows a tubule emanating from a Cav3-positive ring acquired at 1 frame every 10 seconds using a spinning-disk microscope equipped with a SR module.
Time-lapse shows show a tubule emanating from a Bin1-positive ring acquired at 1 frame every 10 s using a spinning-disk microscope equipped with a SR module.
Time-lapse shows a tubule emanating from a Bin1-positive ring acquired at 1 frame every 10 seconds using a spinning-disk microscope equipped with a SR module.
(A) Super-resolution fluorescence microscopy image of an unroofed human myotube transduced with Bin1GFP (green). Insets numbered 1–3 show the circular organization (white arrowheads) of the …
Measurements of ring diameters and tube length in vitro.
Measurements of ring diameters and tube length in cellulo.
(A) Immunofluorescence images of murine primary myotubes transduced with adenoviruses expressing either Bin1GFP or Bin1-ex11GFP and labeled with antibodies against Cav3 (red). Note the presence of …
Quantification of tubule density in Bin1-exon11 vs Bin1 +exon 11.
Quantification of caveolae ring density in Bin1-exon11 vs Bin1 +exon 11.
Quantification of caveolae ring diameter in Bin1-exon11 vs Bin1 +exon 11.
(A) Confocal time-lapse images showing the dynamics of 1 µM Bin1-Alexa647 (magenta) organization in rings and tubes on 5% mol PI4,5P2-containing membranes. Airyscan image acquired at the same region …
(A) High magnification PREM image of an unroofed human myotube transduced with an adenovirus expressing Bin1GFP forming a characteristic pearled tubule with caveolar material. A 3D anaglyph of the …
The unroofed myotube is shown with successive fluorescent microscopy images (Cav3 in red, Bin1GFP in green), low-magnification PREM image (grid appears white), super-resolution image and …
(A–B) PREM images of intact myotubes transduced with Bin1GFP. Yellow arrows indicate necks of caveolae (25–40 nm) seen from the extracellular side of the plasma membrane organized in a circular (A) …
Quantification of Cav3 protein levels in myotubes treated with siRNA against Cav3.
Quantification of Bin1GFP fluorescence intensity in control and siCav3 myotubes.
Western blot uncropped membranes.
(A) High-magnification PREM images of caveolae rings on the cytosolic side of the plasma membrane of sonicated myotubes from patients with the Cav3 R26Q mutation. Caveolae are pseudocolored purple …
Quantification of caveolae ring density ctrl vs R26Q vs R26Q+Cav3-GFP.
Quantification of caveolae ring diameter in ctrl vs R26Q vs R26Q+Cav3-GFP.
Quantification of tubule density in control and patient myotubes transduced with Bin1 +ex11.
Quantification of tubule density in control and patient myotubes transduced with Bin1exon11.
(A) Western-blot analysis of Cav3 protein levels in myotubes from patients with P28L and R26Q mutations (n=3 independent experiments). (B) Densitometric quantification of Cav3 protein levels …
Densitometric quantification of Cav3 protein levels in patient myotubes.
Western blot uncropped membranes.
Western blot uncropped membranes.
High magnification EM images were acquired with electron tomography by collecting images at different tilt angles up to ±60° relative to the plane of the sample with a 2° increment between each frame.
(1) Bin1 molecules polymerize into ring-like structures and recruit Cav3-positive caveolae. (2) Caveolae assemble into circular structures while additional caveolae accumulate at specific spots on …
Antibodies | Provider | Product ref |
---|---|---|
Cav3 (Mouse) monoclonal | BD Biosciences | 610421 |
Cav3 (Rabbit) polyclonal | Abcam | ab2912 |
Cav-1 (Rabbit) polyclonal | Santa Cruz | sc894 |
Cavin 4 (MURC) (Rabbit) polyclonal | Merck | HPA020973 |
DHPR (Mouse) monoclonal | Abcam | ab2862 |
RyR1 (Rabbit) polyclonal | Custom | Marty et al., 1994 |
Bin1 (Mouse) monoclonal | Merck | 05-449-C |
Bin1 (Rabbit) polyclonal | Custom | Nicot et al., 2007 |
GFP (Rabbit) polyclonal | Thermofischer | A11122 |
-actinin 2(Mouse) monoclonal | Sigma Aldrich | A7811 |
Junctophilin 2 (Rabbit) polyclonal | Thermofischer | PA5-20642 |
GAPDH (Rabbit) polyclonal | Santa Cruz | sc25778 |
-tubulin (Mouse) monoclonal | Thermofischer | 236-10501 |
Target | Human siRNASequence |
---|---|
Cav3 (1) | 5’-CAGAUCUCGAGGCCCAGAUCG-3’ |
Cav3 (2) | 5’-AAGCACAAUGGCCCUUCGCUC-3’ |
Target | Murine siRNASequence |
Cav3 | 5’-GGUUCCUCUCAAUUCCAC-3’ |